Randomized Clinical Stroke Trials in 2006

Title: Randomized Clinical Stroke Trials in 2006

Volume: 6 Issue: 1

Author(s): Meheroz H. Rabadi and John P. Blass

Affiliation:

Keywords: Randomized control trials, stroke, rehabilitation

Abstract: This article reviews randomized control trials (RCTs) published in 2006 of various medications evaluated for stroke patients. These trials were primarily efficacy studies. These included aggrenox (an antiplatelet agent), magnesium (to treat arterial spasm after an aneurysmal subarachnoid hemorrhage), NXY (a free radical trapping agent) and albumin which were both tested as a neuroprotectant, amphetamine (to aid motor recovery), fluoxetine (an anti-depressant and anxiolytic) and low molecular weight heparin (for prevention of deep vein thrombosis post-stroke).

Cite this article as:

Rabadi H. Meheroz and Blass P. John, Randomized Clinical Stroke Trials in 2006, Current Vascular Pharmacology 2008; 6(1) . https://dx.doi.org/10.2174/157016108783331259